Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft

Br J Haematol. 2001 Sep;114(3):698-700. doi: 10.1046/j.1365-2141.2001.02965.x.

Abstract

In a randomized study that compared human leucocyte antigen-identical allogeneic granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cell (PBSC) versus bone marrow (BM) transplantation, the expression of activation markers, CD23, CD25 and CD45RO by B cells, was compared in blood before and after G-CSF mobilization and in PBSC versus BM grafts. The fractions of CD23+ and CD25+ B cells were higher in PBSC than in BM grafts. Moreover, we observed a G-CSF-induced increase in B-cell fractions in blood as well as in PBSC grafts when compared with BM grafts. Such an enhanced B-cell activation could contribute to the accelerated kinetics of immuno-haematological reconstitution, the occurrence of acute haemolysis in the ABO minor incompatibility setting, as well as the increased incidence of chronic graft-versus-host disease observed after PBSC transplantation.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / immunology*
  • Biomarkers / blood
  • Bone Marrow Transplantation
  • Flow Cytometry
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hematopoietic Stem Cell Mobilization*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukocyte Common Antigens / analysis
  • Lymphocyte Activation*
  • Receptors, IgE / analysis
  • Receptors, Interleukin-2 / analysis
  • Transplantation, Homologous

Substances

  • Biomarkers
  • Receptors, IgE
  • Receptors, Interleukin-2
  • Granulocyte Colony-Stimulating Factor
  • Leukocyte Common Antigens